This virtual and decentralized trials toolkit is now available to sponsors, CROs and academic research organizations through Epic App Orchard to fast-track COVID drug and vaccine trials and jump-start clinical trials on hold
NEW YORK, NY, July 30, 2020 /24-7PressRelease/ — Rx.Health, the digital health company that created the first enterprise-wide EHR-integrated digital formulary, announced today it has partnered with the AGA and the Clinical Research Strategy Group for the use of the company’s TrialEngage™ digital toolkit. This partnership adds to Rx.Health’s growing list of registry partners and builds on an existing partnership with AGA to create a nationwide clinical trial network, starting with GI.
TrailEngage extends Rx.Health’s offering in clinical engagement to support research engagement in registries, virtual and decentralized trials, care pathways and the collection of real world evidence and digital biomarkers for investigators, Pharma and CROs. It’s proven platform has been shown to have a patient activation rate of 92% and a clinician system usability score of 93%.
According to Dr. Gaurav Narang, VP Strategy at Rx.Health, “TrialEngage for patient recruitment and engagement has become even more relevant in the age of COVID-19. Working within the EHR, the TrialEngage platform allows bulk digital prescriptions to be sent to large patient cohorts. This capability was used to outreach one million New Yorkers during COVID crisis and recruit over 55,000 participants. Using text to enroll, bots and no-app televisits makes recruiting and engaging trial participants an automated and hands-off process. It’s a pretty unique feature that brings best of clinical outreach and research engagement under one umbrella.”
Dr. Chris Fourment, President of Precision Research, a nationwide GI clinical research consortium, echos Dr. Narang’s comments, “We believe the TrialEngage platform will help us recruit faster and more efficiently. TrialEngage uses text messaging, bots, videos and other information to allow potential participants to engage in the recruitment and follow up process on their own terms. Rx.Health has a deep clinical background in GI and that is certainly another plus.”
Chantal Fremont, DNP, MSN, RN, Vice President of Practice and Quality at the AGA weighed in as well saying, “AGA’s mission is to empower clinicians and researchers to improve digestive health. RxHealth and TrialEngage are practical tools that support our work by bringing together the GI community to collaborate on clinical trials that can shape the way we care for patients in the future.”
A spin-off from the Mount Sinai Health System, Rx.Health provides the first EHR-connected digital health prescription platform and formulary that enables care teams, pop health teams and health plans to prescribe evidence-based mobile health applications, multi-media education, wearables, and therapeutics to patients at the point of care. Information on the press-release is available at https://rx.health/trialengage-aga/. To submit interest about your site or to explore partnership, email us at [email protected]
About Precision Research
Precision Research is a Centrally Integrated Research Network or CIRN, whose mission is to streamline the process of clinical research at the site level. Precision centralizes and standardizes many of the key administrative functions of clinical research thereby relieving site burden and increasing both productivity and sustainability. The Precision network includes many of the nations top GI clinical research sites. The network approach to clinical trials can dramatically improve a sponsor’s ability to complete their trial on time, bringing much needed therapeutic options to patients, faster.
About AGA (gastro.org)
The American Gastroenterological Association (AGA) is the trusted voice of the GI community. Founded in 1897, AGA has grown to include more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology.
For the original version of this press release, please visit 24-7PressRelease.com here